Discounted registration will be available for:
Save When You Bring Your Team
Register your staff using the same email domain to take advantage of our "Buy 4 get 1 Free" offer. To receive a complimentary registration link:
- Register 4 attendees using the same email domain
- Send an email to email@example.com requesting your complimentary registration link. (Be sure to include the attendee's first name, last name, and email address.)
Note: Your registration fee supports IPEC-Americas efforts to further academic research in the field of excipients.
The IPEC Foundation sponsors annual scholarships to acknowledge excellence in research conducted at graduate level in the field of Excipients. The scholarships focus on recent significant contributions to formulation science and technology through innovative research with excipients.
The 2020 scholarship recipients are all in their final year of a full-time graduate program leading to the award of a Doctor of Philosophy degree, or equivalent, from a recognized academic institution, and have not completed their defense of their thesis, at the time of their nomination.
These rapid-fire presentations will include summaries of recent research efforts and/or research plans. The summaries will address the success of the research efforts on meeting current needs in the field of formulation science and technology with excipients, as well as how the research findings are likely to impact the future applications of this technology. Finally, the presentations will also illustrate the innovative application of scientific principles in the work.
The topics that will be presented are:
- Optimization of Cholesterol/Polycaprolactone-based Perfluorooctyl Bromide Nanocapsules and Its Impact on X-ray CT Attenuation for Tumor Imaging
- Mucoadhesive In Situ Forming Gel for Oral Mucositis Pain Control
- Towards Quality by Design (QbD) of Pharmaceutical Oral Films Loaded with Poorly Water-Soluble Drugs
Topic: Towards Quality by Design (QbD) of Pharmaceutical Oral Films Loaded with Poorly Water-Soluble Drugs
Eylul Cetindag is a Ph.D. candidate in Chemical Engineering at the New Jersey Institute of Technology. Her thesis advisor is Dr. Rajesh Davé. Eylul completed her undergraduate studies in Food Engineering at Hacettepe University with a minor in Chemical Engineering, Turkey and got her Master’s degree from Micro and Nano Technology at TOBB ETU, Turkey. Her Ph.D. studies focus on the development of regulatory science for the manufacturing of pharmaceutical strip-films loaded with poorly-water soluble drugs. Eylul has 4 published research articles from her Ph.D. studies and several in preparation. She is passionate about applying the experience to the science behind the formulation development.
Topic: Mucoadhesive In Situ Forming Gel for Oral Mucositis Pain Control
Tingting Li is a Ph.D. candidate (Pharmaceutics) in Dr. Diane Burgess’s lab at the University of Connecticut. Tingting received her Bachelor’s degree (Pharmacy) and Master’s degree (Pharmaceutics) from Shandong University in China. Tingting’s graduate research at the University of Connecticut focuses on development and optimization of mucoadhesive in situ forming gels and spray dried mucoadhesive microparticles. She has been working with many mucoadhesive excipients for different formulations. Tingting has 10 papers published, has filed one patent application, and has made 8 poster presentations. With special interests in novel drug delivery systems, Tingting is keen on applying her knowledge and experiences to development and formulation of various drug products after graduation.
Topic: Optimization of Cholesterol/Polycaprolactone-based Perfluorooctyl Bromide Nanocapsules and Its Impact on X-ray CT Attenuation for Tumor Imaging
André Beringhs is a Ph.D. candidate in Pharmaceutical Sciences (Pharmaceutics) at the University of Connecticut, School of Pharmacy. André is passionate about drug delivery and improving the standard of care in human health. During his academic training, André has focused on multidisciplinary projects ranging from oral drug product development to exploratory nanoparticle-based parenteral delivery systems. His multidisciplinary approach to research led to more than 24 scientific publications and 4 patent applications. At the University of Connecticut, André has been working on the development of nanoparticle-based contrast agents employing novel excipients to enable the next generation of medical imaging applications. Tumor imaging has been a major focus of his research as he believes a better understanding of tumor characteristics is of upmost importance for the development of improved delivery systems for cancer therapy.